Emerging Radioligands as Tools to Track Multi-Organ Senescence
Diagnostics · 04.10.2025 · 15 (19) · 2518
DOI: 10.3390/diagnostics15192518 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 04.10.2025. Verfasst von Anna Gagliardi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Division, University Hospital of Parma, Via Antonio Gramsci 14, 43126 Parma, Italy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Senescence is a dynamic, multifaceted process implicated in tissue aging, organ dysfunction, and intricately associated with numerous chronic diseases. As senescent cells accumulate, they drive inflammation, fibrosis, and metabolic disruption through the senescence-associated secretory phenotype (SASP). Despite its clinical relevance, senescence remains challenging to detect non-invasively due to its heterogeneous nature and the lack of universal biomarkers. Recent advances in the development of specific imaging probes for positron emission tomography (PET) enable in vivo visualization of senescence-associated pathways across key organs, such as the lung, heart, kidney, and metabolic processes. For instance, [18F]FPyGal, a β-galactosidase-targeted tracer, has demonstrated selective accumulation in senescent cells in both preclinical and early clinical studies, while FAP-targeted radioligands are emerging as tools for imaging fibrotic remodeling in the lung, liver, kidney, and myocardium. This review examines a new generation of PET radioligands targeting hallmark features of senescence, with the potential to track and measure the process, the ability to be translated into clinical interventions for early diagnosis, and longitudinal monitoring of senescence-driven pathologies. By integrating organ-specific imaging biomarkers with molecular insights, PET probes are poised to transform our ability to manage and treat age-related diseases through personalized approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nuclear Medicine Division, University Hospital of Parma, Via Antonio Gramsci 14, 43126 Parma, Italy.
ORCID-Profile: Anna Gagliardi, Silvia Migliari, Alessandra Guercio, Tiziano Graziani, Veronica Cervati, Livia Ruffini
Zitieren
APA
Gagliardi, A., Migliari, S., Guercio, A., Baldari, G., Graziani, T., Cervati, V., Ruffini, L., & Scarlattei, M. (2025). Emerging Radioligands as Tools to Track Multi-Organ Senescence. Diagnostics, 15(19), 2518. https://doi.org/10.3390/diagnostics15192518
Vancouver
Gagliardi A, Migliari S, Guercio A, Baldari G, Graziani T, Cervati V, et al. Emerging Radioligands as Tools to Track Multi-Organ Senescence. Diagnostics. 2025;15(19):2518. doi:10.3390/diagnostics15192518
BibTeX
@article{Gagliardi2025,
author = {Gagliardi, Anna and Migliari, Silvia and Guercio, Alessandra and Baldari, Giorgio and Graziani, Tiziano and Cervati, Veronica and Ruffini, Livia and Scarlattei, Maura},
title = {Emerging Radioligands as Tools to Track Multi-Organ Senescence},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {19},
pages = {2518},
doi = {10.3390/diagnostics15192518}
}
EUVIMED